(Q36115294)

12 August 2017

What is the effect of adjusting epirubicin doses for body surface area? (English)

1 reference

12 August 2017

2

Twelves CJ

1 reference

12 August 2017

Dobbs NA

1

1 reference

PMCID

2063057

12 August 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

78

1 reference

12 August 2017

662-666

1 reference

12 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.556

12 August 2017

0 references

cites work

Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063057

Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063057

Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063057

Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063057

Is dose normalization to weight or body surface area useful in adults?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063057

Age dependence of the early-phase pharmacokinetics of doxorubicin

2 July 2018

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin

1 reference

12 December 2020

Variability in the pharmacokinetics of epirubicin: a population analysis

1 reference

12 December 2020

Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry

1 reference

12 December 2020

Lean body mass, body surface area and epirubicin kinetics

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.556

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

2063057